Literature DB >> 32489178

Transmissibility of influenza during the 21st-century epidemics, Spain, influenza seasons 2001/02 to 2017/18.

Lidia Redondo-Bravo1, Concepción Delgado-Sanz2, Jesús Oliva2, Tomás Vega3, Jose Lozano3, Amparo Larrauri2.   

Abstract

BackgroundUnderstanding influenza seasonality is necessary for determining policies for influenza control.AimWe characterised transmissibility during seasonal influenza epidemics, including one influenza pandemic, in Spain during the 21th century by using the moving epidemic method (MEM) to calculate intensity levels and estimate differences across seasons and age groups.MethodsWe applied the MEM to Spanish Influenza Sentinel Surveillance System data from influenza seasons 2001/02 to 2017/18. A modified version of Goldstein's proxy was used as an epidemiological-virological parameter. We calculated the average starting week and peak, the length of the epidemic period and the length from the starting week to the peak of the epidemic, by age group and according to seasonal virus circulation.ResultsIndividuals under 15 years of age presented higher transmissibility, especially in the 2009 influenza A(H1N1) pandemic. Seasons with dominance/co-dominance of influenza A(H3N2) virus presented high intensities in older adults. The 2004/05 influenza season showed the highest influenza-intensity level for all age groups. In 12 seasons, the epidemic started between week 50 and week 3. Epidemics started earlier in individuals under 15 years of age (-1.8 weeks; 95% confidence interval (CI):-2.8 to -0.7) than in those over 64 years when influenza B virus circulated as dominant/co-dominant. The average time from start to peak was 4.3 weeks (95% CI: 3.6-5.0) and the average epidemic length was 8.7 weeks (95% CI: 7.9-9.6).ConclusionsThese findings provide evidence for intensity differences across seasons and age groups, and can be used guide public health actions to diminish influenza-related morbidity and mortality.

Entities:  

Keywords:  epidemiology; influenza; influenza-like illnesses; surveillance

Mesh:

Year:  2020        PMID: 32489178      PMCID: PMC7268270          DOI: 10.2807/1560-7917.ES.2020.25.21.1900364

Source DB:  PubMed          Journal:  Euro Surveill        ISSN: 1025-496X


Introduction

Influenza is an important cause of hospital admission and mortality during seasonal influenza epidemics, and as such, constitutes a major issue for public health, healthcare strategy and resource allocation. The latest estimates indicate that there are somewhere between 290,000 and 650,000 seasonal influenza-associated respiratory deaths each year worldwide, mostly affecting individuals over 64 years of age [1]. However, not all influenza epidemics have the same impact and epidemiological features. The impact of influenza on the health of the population depends on the epidemiology of the disease, population susceptibility by age and circulating viruses, as well as other contributing factors such as vaccine coverage, vaccine effectiveness, social mixing patterns, specific humidity and climate [2,3]. For this reason, analysing the start of the epidemic period, as well as the severity of the influenza epidemics every season, is important in order to be able to alert health services and consequently ameliorate the morbidity, mortality and economic costs associated with influenza. Three different indicators have been proposed to assess influenza epidemic/pandemic severity: transmissibility of the virus, clinical severity caused by the infection, and impact on the healthcare sector and on society [4]. Transmissibility, the indicator we focus on in this study, indicates the ease with which a virus may spread person-to-person and is therefore an important determinant of the number of people who will be affected. This can be measured using influenza incidence data obtained through routine influenza surveillance systems. The Spanish Influenza Sentinel Surveillance System (SISSS) provides weekly influenza-like illness (ILI) incidence and percentage of positive ILI samples for influenza, which enables the identification of the start of the epidemics and the calculation of influenza activity levels. This information is crucial to helping guide decisions about public health interventions that can potentially reduce the impact of an influenza epidemic. The moving epidemic method (MEM) has been adopted by the European Centre for Disease Prevention and Control (ECDC) and the World Health Organization Regional Office for Europe (WHO/Europe) to standardise approaches across Europe for calculating epidemic thresholds and intensities. Most countries in the WHO European Region are already using this method for weekly influenza reports [5]. In Spain, it has been used at both regional and national level since 2015 after an agreement between all of the autonomous regions was reached [6]. Consolidating the use of this methodology with a systematic assessment of the transmissibility of the influenza epidemics has also been piloted and implemented in different countries around the world with the same purpose [7-10]. In our study, we focused on characterising the transmissibility during seasonal influenza epidemics, including the 2009 influenza A(H1N1) pandemic, in Spain for the 2001/02 to 2017/18 influenza seasons using the MEM [5,11] and an epidemiological-virological parameter (Goldstein’s proxy), in order to calculate intensity thresholds and intensity levels of the influenza epidemics that have occurred in Spain during the 21st century. This study forms part of an ongoing investigation that includes other analysis using seriousness of disease and impact, the two other indicators proposed, to complete an assessment of seasonal and pandemic influenza severity [4].

Methods

Data source and influenza surveillance parameters

The SISSS has been described in detail in previous articles [12]. However, as a brief overview, sentinel physicians, general practitioners and paediatricians, voluntarily report cases of influenza-like illness (ILI) on a weekly basis, following a definition based on the European Union’s (EU) ILI case definition [13]. They systematically swab, nasal or nasopharyngeal, the first two ILI patients consulting each week and send the swabs to network-affiliated laboratories for influenza virus detection. For the influenza seasons 2001/02 to 2017/18, we used data obtained from the SISSS to estimate a modified version of Goldstein’s proxy for influenza incidence, hereafter referred to as Proxy [14], defined as the weekly age-specific ILI rate (ILI cases/100,000 population) multiplied by the all-ages weekly percentage of samples that test positive for influenza, for all ages and by age group (< 15, 15–64 and > 64 years of age).

Moving epidemic method intensity thresholds and parameters

We calculated the epidemic threshold (ET) and intensity thresholds (ITs) applying the MEM [5,11] to the weekly proxy of influenza incidence from the 2001/02 to 2017/18 influenza seasons, excluding the 2009/10 pandemic season because of the different dynamic of the pandemic [15]. The ET was calculated as the upper limit of the 95% one-sided confidence interval (CI) of the arithmetic mean of the 30 highest pre/post-epidemic weekly rates. The three ITs were calculated as the upper limit of the 40% (IT40), 90% (IT90) and 97.5% (IT97.5) one-sided CIs of the geometric mean of the 30 highest weekly epidemic rates [5,11]. These four cut-off points defined five intensity levels: baseline (below epidemic threshold), low, medium, high and very high intensity. According to the ET, we calculated the starting week of the epidemic period as first week above the ET, and the length of the epidemic period as the number of weeks above the ET. To identify possible differences in the influenza intensity levels, we also applied MEM by age group (< 15, 15–64 and > 64 years of age). We also explored the differences among starting weeks and peak weeks, across age groups by dominant/co-dominant virus. Dominance was defined as a virus circulating during a season at a proportion ≥ 60% and co-dominance when circulating at a proportion > 40% and < 60%. Finally, we calculated the average time (weeks) from the starting week to the peak and the length of the epidemic period (weeks), according to seasonal virus circulation, and established potential differences between dominant virus or mixed circulation by using an analysis of variance (ANOVA) or Student’s t-test, as appropriate, and the corresponding 95% CI. A p value < 0.05 was considered statistically significant. All analyses were conducted using R software version 3.4.0 (R Foundation, Vienna, Austria), and the package mem version 2.14 [15], the official implementation of MEM.

Results

Moving epidemic method characterisation of influenza epidemics’ intensities

The characteristics of the SISSS and the surveillance information from 2001/02 to 2017/18 are presented in Table 1. The number of sentinel specimens tested is presented with the percentage of positivity rate in Figure 1. An increase in the number of specimens tested from 2009 was observed, since systematic swabbing was introduced in the SISSS during the 2009/10 pandemic season.
Table 1

Characteristics of the Spanish Influenza Sentinel Surveillance System (SISSS) and surveillance information, Spain, influenza seasons 2001/02–2017/18

Influenza seasonNumber of sentinel physiciansa Surveilled population (n)Percentage of surveilled populationb (%)ILIs notified (n)Sentinel specimens tested (n)Positivity rate (%)Dominant/co-dominant virusc
2001/02342320,1020.88,4881,21443.4A(H3N2)
2002/03340318,7360.84,6841,43730.5B
2003/04422395,1370.98,0451,41030.9A(H3N2)
2004/05453568,9061.318,2231,78146.0A(H3N2)
2005/06538648,6761.59,0821,88530.6A(H1N1)/B
2006/07668619,8301.412,3811,84845.1A(H3N2)
2007/08646612,6191.412,7322,02349.6A(H1N1)/B
2008/09698667,4141.512,6882,53842.5A(H3N2)
2009/10867842,1901.924,45911,21841.7A(H1N1)pdm09
2010/11841820,2771.817,2245,48245.0A(H1N1)pdm09
2011/12887845,3801.818,8735,85850.1A(H3N2)
2012/13831819,3281.817,8765,17351.5B
2013/14873832,1891.815,8645,06050.3A(H1N1)pdm09/A(H3N2)
2014/15788765,0651.618,9555,10154.5A(H3N2)
2015/16823796,4721.716,9515,30851.1A(H1N1)pdm09
2016/17789779,5361.713,4304,47847.8A(H3N2)
2017/18797800,0161.719,5056,03458.2B/A(H3N2)

ILI: influenza-like illness.

a General practitioners and paediatricians.

b Of the total population of the Spanish regions participating in the SISSS each influenza season.

c A virus that circulated in a proportion ≥ 60% was considered dominant, and co-dominant in a proportion > 40 and < 60%.

Figure 1

Weekly analysed swabs and influenza positivity rate, Spain, influenza seasons 2001/02–2017/18

ILI: influenza-like illness. a General practitioners and paediatricians. b Of the total population of the Spanish regions participating in the SISSS each influenza season. c A virus that circulated in a proportion ≥ 60% was considered dominant, and co-dominant in a proportion > 40 and < 60%. Weekly analysed swabs and influenza positivity rate, Spain, influenza seasons 2001/02–2017/18 Influenza epidemics’ intensity levels for the 2001/02 to 2017/18 influenza seasons were characterised based on the epidemic and intensity thresholds (Figure 2). Fourteen seasons showed a peak with low or medium intensity levels, one season reached a high level (2014/15) and one season presented a very high peak intensity level (2004/05) (Figure 2 and Table 2).
Figure 2

Influenza epidemic thresholds and intensity levels according to the moving epidemic method (MEM), overall (A) and by age group (B,C,D), using Proxya, Spain, influenza seasons 2001/02–2017/18

Table 2

Influenza epidemics by dominant/co-dominant virus, starting week, peak week, length and peak intensity according to the moving epidemic method (MEM) using Proxya, Spain, influenza seasons 2001/02–2017/18

Influenza seasonDominant/co-dominant virusb Starting weekPeak weekEpidemic length (weeks)Peak intensityc
2001/02A(H3N2)1410Low
2002/03B51411Low
2003/04A(H3N2)43479Low
2004/05A(H3N2)50212Very high
2005/06A(H1N1)/B8117Low
2006/07A(H3N2)268Medium
2007/08A(H1N1)/B48214Low
2008/09A(H3N2)5019Medium
2009/10A(H1N1)pdm09404611Medium
2010/11A(H1N1)pdm0951210Medium
2011/12A(H3N2)52711Medium
2012/13B3810Medium
2013/14A(H1N1)pdm09/A(H3N2)148Medium
2014/15A(H3N2)2510High
2015/16A(H1N1)pdm094910Low
2016/17A(H3N2)5039Medium
2017/18B/A(H3N2)50313Medium

a Proxy is defined as weekly age-specific influenza-like illness (ILI) cases/100,000 population multiplied by the all-ages weekly percentage of samples that test positive for influenza.

b A virus that circulated in a proportion ≥ 60% was considered dominant, and co-dominant in a proportion> 40 and < 60%.

c Level of intensity reached in the week with maximum influenza activity of the season.

Influenza epidemic thresholds and intensity levels according to the moving epidemic method (MEM), overall (A) and by age group (B,C,D), using Proxya, Spain, influenza seasons 2001/02–2017/18 a Proxy is defined as weekly age-specific influenza-like illness (ILI) cases/100,000 population multiplied by the all-ages weekly percentage of samples that test positive for influenza. a Proxy is defined as weekly age-specific influenza-like illness (ILI) cases/100,000 population multiplied by the all-ages weekly percentage of samples that test positive for influenza. b A virus that circulated in a proportion ≥ 60% was considered dominant, and co-dominant in a proportion> 40 and < 60%. c Level of intensity reached in the week with maximum influenza activity of the season. Influenza A(H3N2) has been the virus circulating as dominant/co-dominant most often (10 seasons) and in one of the seasons, the intensity reached was very high, in one it was high, in six it was medium and in two it was low. When influenza A(H1N1)/A(H1N1)pdm09 virus was dominant/co-dominant (six seasons), the intensity reached was medium in three and low in three. Finally, when influenza B virus was the dominant/co-dominant virus (five seasons), the intensity reached was low in three and medium in two (Table 2). ET and IT were higher for individuals under 15 years of age than for the 15 to 64, and over 64 years of age groups (Figure 2 and Table 3). In the under 15 years of age group, two seasons (2004/05 and 2009/10) reached a very high intensity level, and one reached a high level (2014/15). For the 15 to 64 and over 64 years of age groups, the intensity was very high only in 2004/05; the rest of the seasons presented a medium or low intensity level (Figure 2).
Table 3

Influenza epidemic thresholds and intensity thresholds according to the moving epidemic method (MEM) using Proxya, Spain, influenza seasons 2001/02–2017/18

Age group (years)Epidemic thresholdsIntensity thresholds
LowMediumHigh
<1552.4285.3457.3563.4
15–6429.0105.3220.6305.8
> 6413.9438.1117.4193.0
All ages29.3132.3237.1306.8

a Proxy is defined as weekly age-specific influenza-like illness (ILI) cases/100,000 population multiplied by the all-ages weekly percentage of samples that test positive for influenza.

a Proxy is defined as weekly age-specific influenza-like illness (ILI) cases/100,000 population multiplied by the all-ages weekly percentage of samples that test positive for influenza.

Epidemic start and total length assessment

We also used MEM with Proxy to study the influenza epidemics’ start and peak weeks, by age group. From 2001/02 until 2017/18, besides the 2009/10 pandemic which started in week 40, the earliest epidemic started in week 48 (2007/08), and the latest in week 8 (2005/06). In 12 seasons, the epidemic started between week 50 and week 3. By age group, we estimated that during the study period, influenza epidemics started earlier in those under 15 years of age (–1.8 weeks; CI 95%: –2.8 to –0.7) than in those over 64 years of age, when B virus circulated as dominant/co-dominant considering the virus circulation within the entire season. There were not significant differences regarding the starting week when compared with the 15 to 64 years of age group (Table 4). Influenza epidemics did not peak earlier in individuals under 15 years than for those 15 to 64 or those over 64 years of age, regardless of the virus type/subtype (Table 4).
Table 4

Differences in starting and peak weeks by age group and dominant/co-dominant influenza virus, using Proxya, Spain, influenza seasons 2001/02–2017/18

DifferencesAge groups compared (years)Dominant/co-dominant virusb Mean95% CI
LowerUpper
Among starting weeks< 15 vs 15–64A(H1N1)c −0.2−1.20.8
A(H3N2)0.0−0.80.8
B−0.8−2.30.8
< 15 vs > 64A(H1N1)c −0.6−2.81.6
A(H3N2)0.0−0.80.8
B−1.8−2.8−0.7
Among peak weeksd < 15 vs 15–64A(H1N1)c 0.0−1.51.5
A(H3N2)0.0−0.70.7
B−1.3−3.10.6
< 15 vs > 64A(H1N1)c 0.8−1.73.3
A(H3N2)−0.3−1.00.5
B0.5−2.03.0

CI: confidence interval.

a Proxy is defined as weekly age-specific influenza-like illness (ILI) cases/100,000 population multiplied by the all-ages weekly percentage of samples that test positive for influenza.

b A virus that circulated within the season in a proportion ≥ 60% was considered dominant and co-dominant in a proportion > 40 and > 60%.

c Influenza A(H1N1)pdm09 and A(H1N1) virus.

d Influenza season 2015/16 was excluded from this analysis as there was not a clear peak week; a plateau was observed between weeks 7 and 12.

CI: confidence interval. a Proxy is defined as weekly age-specific influenza-like illness (ILI) cases/100,000 population multiplied by the all-ages weekly percentage of samples that test positive for influenza. b A virus that circulated within the season in a proportion ≥ 60% was considered dominant and co-dominant in a proportion > 40 and > 60%. c Influenza A(H1N1)pdm09 and A(H1N1) virus. d Influenza season 2015/16 was excluded from this analysis as there was not a clear peak week; a plateau was observed between weeks 7 and 12. In a sensitivity analysis, considering the dominant/co-dominant virus during the starting weeks of the epidemic, we obtained differences in the timing of the peak week in individuals under 15 years vs those over 64 years of age (–2.3 weeks; 95% CI: –3.3 to –1.3) when B circulated as dominant/co-dominant (data not shown). We also examined the time from start to peak and total epidemic length according to the dominant/co-dominant influenza virus. Overall, across the 17 influenza seasons studied, the average time from start to peak was 4.3 weeks and the average total epidemic length was almost 9 weeks (Table 5). No differences were found in the number of weeks from start to peak (p = 0.47) according to the dominant virus. The length of the epidemic was longer for seasons with a predominance influenza B virus (10.5 weeks) than those seasons with a predominance of influenza A(H1N1)pdm09 or A(H3N2) virus (8.0 and 8.3 weeks, respectively); these differences were statistically significant. We also assessed these two parameters in seasons with circulating virus co-dominance vs seasons with only one dominant virus and found no significant differences (Table 5).
Table 5

Average weeks from start to peak week, and influenza epidemic length by dominant/co-dominant virus, using Proxya, Spain, influenza seasons 2001/02–2017/18

Influenza virus circulationAverage time from start to peak (weeks)Epidemic length (weeks)
Mean95% CIp valueMean95% CIp value
LowerUpperLowerUpper
Dominant/co-dominant virusb A(H1N1)c 4.42.36.50.478.06.59.50.03
A(H3N2)3.93.04.78.37.59.0
B5.04.15.910.58.712.3
Dominance/co-dominance seasond Dominance seasons4.33.45.20.968.47.99.00.13
Co-dominance seasons4.32.95.810.05.814.2
Overall4.33.65.0NA8.77.99.6NA

CI: confidence interval; NA: not applicable.

a Proxy is defined as the weekly age-specific influenza-like illness (ILI) cases/100,000 population multiplied by the all-ages weekly percentage of samples that test positive for influenza.

b A type of virus that circulated in a proportion ≥ 60% was considered dominant, and co-dominant in a proportion > 40 and  <60%. Within influenza A virus, the same rule is applied to dominant/co-dominant subtype.

c Influenza A(H1N1)pdm09 and A(H1N1) virus.

d Dominance season is when a dominant influenza virus has been circulating and co-dominance season is when a type/subtype co-dominant virus has been circulating.

CI: confidence interval; NA: not applicable. a Proxy is defined as the weekly age-specific influenza-like illness (ILI) cases/100,000 population multiplied by the all-ages weekly percentage of samples that test positive for influenza. b A type of virus that circulated in a proportion ≥ 60% was considered dominant, and co-dominant in a proportion > 40 and  <60%. Within influenza A virus, the same rule is applied to dominant/co-dominant subtype. c Influenza A(H1N1)pdm09 and A(H1N1) virus. d Dominance season is when a dominant influenza virus has been circulating and co-dominance season is when a type/subtype co-dominant virus has been circulating.

Discussion

This study characterises the transmissibility of the first 17 seasonal influenza epidemics, including the 2009 influenza A(H1N1) pandemic, that have occurred in Spain since 2001/02. We used the MEM to define influenza-intensity levels and to study the differences in the temporal presentation of influenza epidemics. Using a parameter that includes both epidemiological and virological information (Proxy), individuals under 15 years of age presented higher transmissibility than older age groups. Overall, influenza epidemics started earlier in individuals under 15 years of age than in the those over 64 years of age when influenza B was the dominant/co-dominant virus. Most influenza seasons started between mid-December and the third week of January, the average from start to peak was just over 4 weeks and the average total epidemic length almost 9 weeks. We evaluated the transmissibility of the 17 influenza epidemics with the MEM. This is a robust tool to calculate the epidemic threshold and identify the week when influenza epidemics start; this is key to helping public health authorities plan and organise healthcare resources during the influenza season. We used the MEM because it determines the levels of influenza activity mathematically rather than using a qualitative assessment, compared with previous qualitative EISN (European Influenza Surveillance Network) intensity indicators, thereby avoiding frequent inconsistencies in surveillance reporting. Compared with other existing methods, the advantages of MEM are its simplicity, flexibility and intuitiveness. Other methods aiming to detect the start of influenza activity rely on relatively complex mathematical models [16-19] that require specialist programs which limits their implementation. The MEM method is developed on open-source software which makes its implementation user-friendly. However, because it requires a minimum of 5 years of consistent historical influenza data to accurately calculate values, similar analyses may not be possible in countries where these historical data are not available. In this study we calculated common MEM thresholds, to retrospectively analyse the entire study period and compare the intensity levels by age group and the inter-season variability of transmissibility. For routine surveillance purposes, we use a MEM approach in which the on-going influenza season is compared with recent seasons through a moving period of 10 previous influenza epidemics length. Even though including more than 10 seasons can potentially increase accuracy, it can also make the model more susceptible to be affected by secular trends [5]. Season-specific thresholds might produce some controversial intensity levels, because such characterisation closely depends on recent historical influenza data. For example, seasons of extremely high intensity might impact on the model and the highest intensity thresholds, what will allow characterising the following high intensity epidemics within lower thresholds. This fully supports the idea of assessing the intensity of an influenza epidemic, in terms of comparison with the intensity of previous influenza seasons. In our study, we used a modified version Goldstein’s proxy for as parameter to calculate the epidemics’ characteristics and intensity thresholds. The EU ILI case definition is based on signs and symptoms, which cannot be distinguished from other respiratory illnesses with similar clinical presentations, especially respiratory syncytial virus (RSV) infection in children. To make the proxy more accurate though, we applied the influenza positivity rate to ILI rates and consequently accounted for confirmed influenza cases (Proxy). In addition, by using the amended Proxy we avoided the disadvantage of purely using a percentage of virologically positive specimens, especially at the start and the end of the epidemic when low sample sizes inherently unstable may bias results. This was the rationale behind the use of Proxy in this study, in accordance with other authors who have used positivity data to assess influenza epidemics’ intensity [20]. Goldstein’s proxy has also been used in different models to calculate other indicators of influenza severity such as influenza-attributable mortality [4]. Having information on influenza intensity by age group is key to ensuring optimal resource allocation and healthcare setting management [21,22]. Our results showed higher influenza transmissibility for individuals under 15 years of age during the 2009 influenza A(H1N1) pandemic, which is similar to the transmission levels already described by other authors [23,24]. This group was responsible for the high overall transmissibility detected during the pandemic. Individuals under 15 years of age were also heavily affected in the 2004/05 influenza season, when an influenza A(H3N2) virus drift variant circulated [7]. Notably, we found increased incidence rates in all age groups during this season. Individuals under 15 years of age were also heavily affected during the A(H3N2) virus-dominant 2014/15 influenza season. This season had a reportedly low in-season vaccine effectiveness against A(H3N2), which is in line with the substantial impact of the 2014/15 influenza epidemic in Spain on population mortality [25]. Influenza seasons 2016/17 and 2017/18, which had dominance/co-dominance of A(H3N2) virus, but with a medium intensity overall, presented higher epidemic intensities in those over 64 years of age than in previous seasons. These differences may be explained by the interaction of several factors, including vaccine coverage, vaccine effectiveness, antigenic changes and immunological memory [26-28]. Some authors have proposed the possibility of children acting as drivers of influenza epidemics [29,30] or as playing a primary role in intra-household transmission [31], with their role in influenza B outbreaks being highlighted [32,33]. However, there is not yet broad agreement on this issue [29]. In the present study, we detected a delay of ca 2 weeks in individuals over 64 years of age when compared with those under 15 years of age when the circulating virus was influenza B. This would support children being drivers of epidemics when influenza B virus is predominant. It has been noted by other authors that early starting of influenza activity in children could also be influenced by the presence of other circulating viruses, such as RSV and parainfluenza, which can affect children considerably [34,35]. However, by using Goldstein’s proxy we should have largely avoided the influence of other viruses on the results. It could also be argued that the earlier influenza activity start in children might be related to different health seeking behaviour, with children consulting earlier after symptom onset than other age groups, not only because of clinical factors, but also with a parent’s risk-perception after seeing information in the media in a specific season. However, that this earlier epidemic start in individuals under 15 years of age is only detected when influenza B is the dominant/co-dominant virus, and not when A viruses are dominant/co-dominant, supports the notion of individuals under 15 years of age being drivers of influenza B epidemics. In contrast, we found no differences in the peak week by type/subtype of the dominant virus among age groups. These data suggest that although children have an earlier presentation than adults when B viruses circulate, the highest activity is reached at the same time in both groups. This may reflect slower or interrupted transmission among children, being explained by the intervention of the Christmas holiday period, which would halt school-associated transmission and slow the progression of the epidemic [36]. We observed an average of 4 weeks between the start of the epidemic and its peak; this is in accordance with a recently published study carried out in Scotland using primary care virological data. This finding demonstrates that MEM is a robust tool, not only to set intensity thresholds but also to predict the weeks of maximum intensity once the epidemic baseline has been exceeded [9]. Regarding the total length of the epidemics, those influenza seasons with B virus dominance/co-dominance lasted ca 2 weeks longer than those with A viruses. We believe that this can probably be explained by the earlier start in children. Overall, once the epidemic threshold is crossed, healthcare services can expect an average of 9 weeks of influenza-related demands. Taking the differences in intensity regarding the dominant/co-dominant virus circulating into account, we observed that influenza B epidemics present lower intensity but last longer. This means that the amount of resources allocated in the higher demand of medical attention could be smaller but during a more prolonged period. On the contrary, during influenza A epidemics, the probability of reaching a medium (during A(H1N1)pdm09 epidemics) or high (during A(H3N2) epidemics) level of intensity is higher but the epidemic length is shorter. For this reason, the amount of resources and their organisation must be envisaged to diminish the effects of influenza epidemics considering the dominant/co-dominant virus circulating. A main limitation of our study is that changes were introduced within the SISSS over the seasons. One of most important was the introduction of systematic swabbing in the SISSS during the 2009/10 pandemic season (Figure 1) [37], which made the age-positivity rate much closer to the real situation. Before the 2009/10 pandemic, there was a tendency to collect fewer specimens than recommended as the age of patients increased, with this especially being the case for patients 65 years of age and above [38]. However, after systematic swabbing was introduced, the frequency of swabbing became more homogeneous among all age groups [39]. Thus, the data should before 2009 should be considered less representative while that from 2009 onwards should be considered more representative of the surveyed population. Another limitation is that there was a change in the ILI case definition between the influenza season 2008/09 and the 2009/10 pandemic, from the International Classification of Health Problems in Primary Care (ICHPPC-2) definition [40] to the EU ILI case definition [13]. Although there is no direct comparison between these two definitions, the EU ILI case definition has been reported to have higher sensitivity than the WHO and the US Centers for Disease Control and Prevention (CDC) case definition [41]. It is thus possible that it performs different than the definition of the ICHPPC which could influence the intensity level of the epidemics after the 2009/10 season. However, because we calculated the MEM IT with the values of all epidemics from 2001/02 to 2017/18, the possible differences in such a characterisation probably decreases. Nevertheless, the SISSS has demonstrated considerable flexibility in order to incorporate changes in the dynamic and methods of surveillance [42]. We consider that the main strength of our study to be the long time period and number of influenza seasons with epidemiological and virological data included in series, overall and by age group, obtained from a well-established influenza sentinel surveillance system [6,33].

Conclusion

Applying our method as part of weekly influenza surveillance during subsequent influenza seasons and possible pandemics will allow for the assessment of when influenza activity will start in real-time. This will further allow to predict when there will be maximum pressure on the healthcare system so as to guide public health measures and resource planning in a way that may reduce the impact of the morbidity and mortality associated with seasonal and pandemic influenza. We believe that the approach shown might be very useful to any European country to identify the starting of a seasonal influenza epidemic. In addition, we are able to inform on the level of influenza transmissibility, and therefore how easily the epidemic will spread among various population groups. Those seasons with a considerable circulation of B virus would warrant a closer monitoring of infection in children because the disease would likely be starting within this population group.
  32 in total

Review 1.  Temporally Varying Relative Risks for Infectious Diseases: Implications for Infectious Disease Control.

Authors:  Edward Goldstein; Virginia E Pitzer; Justin J O'Hagan; Marc Lipsitch
Journal:  Epidemiology       Date:  2017-01       Impact factor: 4.822

2.  Changes in genetically drifted H3N2 influenza A viruses and vaccine effectiveness in adults 65 years and older during the 2016/17 season in Denmark.

Authors:  Ramona Trebbien; Thea K Fischer; Tyra G Krause; Lene Nielsen; Xiaohui Chen Nielsen; Lenette Sandborg Weinreich; Joanna Lis-Tønder; Marianne Nielsine Skov; Claus Bohn Christiansen; Hanne-Dorthe Emborg
Journal:  J Clin Virol       Date:  2017-06-29       Impact factor: 3.168

3.  Using data on social contacts to estimate age-specific transmission parameters for respiratory-spread infectious agents.

Authors:  Jacco Wallinga; Peter Teunis; Mirjam Kretzschmar
Journal:  Am J Epidemiol       Date:  2006-09-12       Impact factor: 4.897

4.  Estimates of global seasonal influenza-associated respiratory mortality: a modelling study.

Authors:  A Danielle Iuliano; Katherine M Roguski; Howard H Chang; David J Muscatello; Rakhee Palekar; Stefano Tempia; Cheryl Cohen; Jon Michael Gran; Dena Schanzer; Benjamin J Cowling; Peng Wu; Jan Kyncl; Li Wei Ang; Minah Park; Monika Redlberger-Fritz; Hongjie Yu; Laura Espenhain; Anand Krishnan; Gideon Emukule; Liselotte van Asten; Susana Pereira da Silva; Suchunya Aungkulanon; Udo Buchholz; Marc-Alain Widdowson; Joseph S Bresee
Journal:  Lancet       Date:  2017-12-14       Impact factor: 79.321

5.  Pilot study to harmonize the reported influenza intensity levels within the Spanish Influenza Sentinel Surveillance System (SISSS) using the Moving Epidemic Method (MEM).

Authors:  M Bangert; H Gil; J Oliva; C Delgado; T Vega; S DE Mateo; A Larrauri
Journal:  Epidemiol Infect       Date:  2016-12-05       Impact factor: 4.434

6.  Detecting the start of an influenza outbreak using exponentially weighted moving average charts.

Authors:  Stefan H Steiner; Kristina Grant; Michael Coory; Heath A Kelly
Journal:  BMC Med Inform Decis Mak       Date:  2010-06-29       Impact factor: 2.796

Review 7.  Harmonizing influenza primary-care surveillance in the United Kingdom: piloting two methods to assess the timing and intensity of the seasonal epidemic across several general practice-based surveillance schemes.

Authors:  H K Green; A Charlett; J Moran-Gilad; D Fleming; H Durnall; D Rh Thomas; S Cottrell; B Smyth; C Kearns; A J Reynolds; G E Smith; A J Elliot; J Ellis; M Zambon; J M Watson; J McMenamin; R G Pebody
Journal:  Epidemiol Infect       Date:  2014-07-15       Impact factor: 4.434

8.  Influenza surveillance in Europe: establishing epidemic thresholds by the moving epidemic method.

Authors:  Tomás Vega; Jose Eugenio Lozano; Tamara Meerhoff; René Snacken; Joshua Mott; Raul Ortiz de Lejarazu; Baltazar Nunes
Journal:  Influenza Other Respir Viruses       Date:  2012-08-16       Impact factor: 4.380

9.  Associations between Meteorological Parameters and Influenza Activity in Berlin (Germany), Ljubljana (Slovenia), Castile and León (Spain) and Israeli Districts.

Authors:  Radina P Soebiyanto; Diane Gross; Pernille Jorgensen; Silke Buda; Michal Bromberg; Zalman Kaufman; Katarina Prosenc; Maja Socan; Tomás Vega Alonso; Marc-Alain Widdowson; Richard K Kiang
Journal:  PLoS One       Date:  2015-08-26       Impact factor: 3.240

10.  Estimating the burden of seasonal influenza in Spain from surveillance of mild and severe influenza disease, 2010-2016.

Authors:  Jesús Oliva; Concepción Delgado-Sanz; Amparo Larrauri
Journal:  Influenza Other Respir Viruses       Date:  2017-12-15       Impact factor: 4.380

View more
  2 in total

1.  Influenza hospitalizations in children under 1 year old in Spain: the importance of maternal immunization.

Authors:  Jesús San Román Montero; Ruth Gil-Prieto; Rubén Jiménez Martín; Raúl Ortiz de Lejarazu; Carmen Gallardo-Pino; Angel Gil de Miguel
Journal:  Hum Vaccin Immunother       Date:  2020-12-22       Impact factor: 3.452

2.  An Economic Evaluation of the Adjuvanted Quadrivalent Influenza Vaccine Compared with Standard-Dose Quadrivalent Influenza Vaccine in the Spanish Older Adult Population.

Authors:  Anna Fochesato; Sara Sottile; Andrea Pugliese; Sergio Márquez-Peláez; Hector Toro-Diaz; Ray Gani; Piedad Alvarez; Jesús Ruiz-Aragón
Journal:  Vaccines (Basel)       Date:  2022-08-20
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.